Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.50
Delayed Data
As of 4:00pm ET
 +0.05 / +2.04%
Today’s Change
1.00
Today|||52-Week Range
8.46
-1.96%
Year-to-Date
No recent news for Sunesis Pharmaceuticals Inc.

Today’s Trading

Previous close2.45
Today’s open2.42
Day’s range2.26 - 2.50
Volume929,224
Average volume (3 months)1,090,755
Market cap$166.0M
Dividend yield--
Data as of 4:00pm ET, 04/01/2015

Growth & Valuation

Earnings growth (last year)-15.15%
Earnings growth (this year)+17.76%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.93%
P/E ratioNM
Price/Sales26.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp+0.10+0.39%
ACRXAcelRx Pharmaceutica...+0.06+1.55%
--China Health Group I...+0.01+4.30%
EBIOEleven Biotherapeuti...-0.15-1.68%
Data as of 4:00pm ET, 04/01/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$5.7M
Annual profit (last year)-$43.0M
Net profit margin-749.95%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account